1: Kumar S, Kumari N, Mittal RD, Ghoshal UC. Pepsinogen-II 100 bp ins/del gene
polymorphism and its elevated circulating levels are associated with gastric
cancer, particularly with Helicobacter pylori infection and intestinal
metaplasia. Gastric Cancer. 2016 Jul;19(3):808-16. doi:
10.1007/s10120-015-0550-8. Epub 2015 Oct 20. PubMed PMID: 26486507.
2: He C, Xu Q, Tu H, Sun L, Gong Y, Liu J, Yuan Y. Polymorphic rs9471643 and
rs6458238 upregulate PGC transcription and protein expression in overdominant or
dominant models. Mol Carcinog. 2016 May;55(5):586-99. doi: 10.1002/mc.22305. Epub
2015 Apr 7. PubMed PMID: 25857852.
3: He CY, Sun LP, Xu Q, Liu JW, Jiang JY, Dong NN, Yuan Y. PGC TagSNP and its
interaction with H. pylori and relation with gene expression in susceptibility to
gastric carcinogenesis. PLoS One. 2014 Dec 31;9(12):e115955. doi:
10.1371/journal.pone.0115955. eCollection 2014. PubMed PMID: 25551587; PubMed
Central PMCID: PMC4281127.
4: Massarrat S, Haj-Sheykholeslami A, Mohamadkhani A, Zendehdel N, Aliasgari A,
Rakhshani N, Stolte M, Shahidi SM. Pepsinogen II can be a potential surrogate
marker of morphological changes in corpus before and after H. pylori eradication.
Biomed Res Int. 2014;2014:481607. doi: 10.1155/2014/481607. Epub 2014 Jun 17.
PubMed PMID: 25028655; PubMed Central PMCID: PMC4083213.
5: Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M,
Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H,
Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M. Cancer
development based on chronic active gastritis and resulting gastric atrophy as
assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct
3. PubMed PMID: 24009139.
6: Cao XY, Jia ZF, Jin MS, Cao DH, Kong F, Suo J, Jiang J. Serum pepsinogen II is
a better diagnostic marker in gastric cancer. World J Gastroenterol. 2012 Dec
28;18(48):7357-61. doi: 10.3748/wjg.v18.i48.7357. PubMed PMID: 23326145; PubMed
Central PMCID: PMC3544042.
7: Tahara T, Shibata T, Okubo M, Yamashita H, Yoshioka D, Yonemura J, Maruyama N,
Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Yamada H, Nakamura
M, Arisawa T, Hirata I. Examination of serum pepsinogen in functional dyspepsia.
Hepatogastroenterology. 2012 Nov-Dec;59(120):2516-22. doi: 10.5754/hge10604.
PubMed PMID: 23178618.
8: Zheng KC, Aoki K, Li XQ, Lin SG, Wu BS, Zhong WL, Chen TH, Lin S, You JW, Su
C. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the
residents of two cities in china with distinct mortality rates of gastric cancer.
Tohoku J Exp Med. 2012;228(4):289-94. PubMed PMID: 23117263.
9: He CY, Sun LP, Gong YH, Xu Q, Dong NN, Yuan Y. Serum pepsinogen II: a
neglected but useful biomarker to differentiate between diseased and normal
stomachs. J Gastroenterol Hepatol. 2011 Jun;26(6):1039-46. doi:
10.1111/j.1440-1746.2011.06692.x. PubMed PMID: 21303408.
10: Sun LP, Gong YH, Dong NN, Wang L, Yuan Y. [Correlation of pepsinogen C (PGC)
gene insertion/deletion polymorphism to PGC protein expression in gastric mucosa
and serum]. Ai Zheng. 2009 May;28(5):487-92. Chinese. PubMed PMID: 19624876.
11: Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, Shimosegawa T.
Serum biomarker tests are useful in delineating between patients with gastric
atrophy and normal, healthy stomach. World J Gastroenterol. 2009 Feb
21;15(7):853-9. PubMed PMID: 19230047; PubMed Central PMCID: PMC2653386.
12: Sun LP, Zhang Y, Liu YE, Chen W, Yuan Y. [Interaction between an
insertion/deletion polymorphism in pepsinogen C and Helicobacter pylori infection
in the development of gastric cancer]. Zhonghua Zhong Liu Za Zhi. 2008
Sep;30(9):644-8. Chinese. PubMed PMID: 19173902.
13: Sun LP, Guo XL, Zhang Y, Chen W, Bai XL, Liu J, Yuan Y. Impact of pepsinogen
C polymorphism on individual susceptibility to gastric cancer and its
precancerous conditions in a Northeast Chinese population. J Cancer Res Clin
Oncol. 2009 Aug;135(8):1033-9. doi: 10.1007/s00432-008-0539-3. Epub 2009 Jan 9.
PubMed PMID: 19132389.
14: Pinto-Correia AL, Pinto D, Pereira D, Rodrigues H, de Sousa JA, Sousa H,
Sousa B, Sousa S, Lopes C, Medeiros R. Overall survival in women with breast
cancer: the influence of pepsinogen C gene polymorphism. DNA Cell Biol. 2008
Jun;27(6):333-6. doi: 10.1089/dna.2007.0713. PubMed PMID: 18447628.
15: Parthasarathy G, Maroju NK, Kate V, Ananthakrishnan N, Sridhar MG. Serum
pepsinogen I and II levels in various gastric disorders with special reference to
their use as a screening test for carcinoma stomach. Trop Gastroenterol. 2007
Oct-Dec;28(4):166-70. PubMed PMID: 18416347.
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Human Gastricsin(PGII),PGC Recombinant Protein” Cancel reply
Reviews
There are no reviews yet.